144 related articles for article (PubMed ID: 6893891)
1. Pharmacological properties of a potent neuroleptic drug octoclothepin.
Metysová J; Metys J; Dlabac A; Kazdová E; Valchár M
Acta Biol Med Ger; 1980; 39(6):723-40. PubMed ID: 6893891
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
Dlabac A; Metys J; Metysová J
Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
[No Abstract] [Full Text] [Related]
3. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
Mikhaĭlova TV; Terekhina AI; Gilev AP
Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
[No Abstract] [Full Text] [Related]
4. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug.
Uchida S; Honda F; Otsuka M; Satoh Y; Mori J; Ono T; Hitomi M
Arzneimittelforschung; 1979; 29(10):1588-94. PubMed ID: 42413
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. I. The action on the central nervous system in rodents.
Metysová J; Metys J
Act Nerv Super (Praha); 1971; 13(3):185-6. PubMed ID: 5165408
[No Abstract] [Full Text] [Related]
6. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. II. Influence on behaviour in rats.
Kazdová E; Metysová J; Dlabac A
Act Nerv Super (Praha); 1971; 13(3):186-7. PubMed ID: 5113831
[No Abstract] [Full Text] [Related]
7. Pharmacological comparison of a new neuroleptic drug methiothepin with octoclothepin and chlorpromazine.
Metysová J
Act Nerv Super (Praha); 1968 Oct; 10(3):332-3. PubMed ID: 5702554
[No Abstract] [Full Text] [Related]
8. Gastrointestinal prokinetic and antiemetic effects of a new substituted pyrimidinO 6553 (2-methylamino-4-N-methylpiperazino-5-thiomethyl-6-chloropyrimidine hydrochloride).
Loiseau G; Millischer R; Donadieu AM; Marquet JP
Arzneimittelforschung; 1977; 27(3):606-11. PubMed ID: 577427
[TBL] [Abstract][Full Text] [Related]
9. The effect of octoclothepin and perphenazine on behaviour in rats with different exploration and defecation rates.
Kazdová E; Dlabac A; Benesová O
Act Nerv Super (Praha); 1974 Mar; 16(1):73-5. PubMed ID: 4454952
[No Abstract] [Full Text] [Related]
10. Proceedings: Stereospecificity of neuroleptic effects in the 10-piperazino-10, 11-dihydrodibenzo (b, f) thiepin series.
Metysová J; Protiva M
Act Nerv Super (Praha); 1975; 17(4):218-9. PubMed ID: 1221761
[No Abstract] [Full Text] [Related]
11. Comparison of the behavioural effect of octoclothepin and perphenazine in rats.
Kazdová E
Act Nerv Super (Praha); 1970; 12(3):266. PubMed ID: 5457454
[No Abstract] [Full Text] [Related]
12. Comparative study on the pharmacological properties of the neuroleptics octoclothepine and chlorpromazine.
Metysová J; Metys J
Act Nerv Super (Praha); 1967 Nov; 9(4):424-5. PubMed ID: 5612966
[No Abstract] [Full Text] [Related]
13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
14. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
15. Toxicological and pharmacological effects of D-arginine.
Navarro E; Alonso SJ; Martín FA; Castellano MA
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):149-54. PubMed ID: 16128908
[TBL] [Abstract][Full Text] [Related]
16. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of deltamethrin on the central nervous system.
Pham Huu Chanh ; Navarro-Delmasure C; Pham Huu Chanh ; Cheav SL; Ziade F; Samaha F
Arzneimittelforschung; 1984; 34(2):175-81. PubMed ID: 6539110
[TBL] [Abstract][Full Text] [Related]
18. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
19. A method for quantitative estimation of the central depressant effect of neuroleptics on the spontaneous motility of rats.
Sandberg F
Exp Med Surg; 1967; 25(1):236-43. PubMed ID: 5618936
[No Abstract] [Full Text] [Related]
20. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
